Document:

Corindus Vascular Robotics, Inc. 8-K

Exhibit 10.2

 

REGISTRATION RIGHTS AGREEMENT 

 

This
Registration Rights Agreement (this “Agreement”) is dated as of March 12, 2019, by and among
Corindus Vascular Robotics, Inc., a Delaware corporation (the “Company”), and the several signatories
hereto.

 

Recitals

 

This Agreement is made pursuant to the
Securities Purchase Agreement (the “Purchase Agreement”), dated as of March 12, 2019, between the Company
and each purchaser signatory thereto (each a “Purchaser” and collectively, the “Purchasers”).

 

Now,
Therefore, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and each of the Holders hereby agree as follows:

 

1.          
Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall
have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following
meanings:

 

“Advice” has
the meaning set forth in Section 6(d).

 

“Agreement” has
the meaning set forth in the preamble.

 

“Company” has
the meaning set forth in the preamble.

 

“Effective Date”
means the date that the Registration Statement filed pursuant to Section 2(a) is first declared effective by the Commission.

 

“Effectiveness Deadline”
means, with respect to the Initial Registration Statement or the New Registration Statement, the 180th calendar day
following the Closing Date; provided, however, that if the Effectiveness Deadline falls on a Saturday, Sunday or
other day that the Commission is closed for business, the Effectiveness Deadline shall be extended to the next Business Day on
which the Commission is open for business.

 

“Effectiveness Period”
has the meaning set forth in Section 2(b).

 

“Event” has the
meaning set forth in Section 2(c).

 

“Event Date”
has the meaning set forth in Section 2(c).

 

“Filing Deadline”
means, with respect to the Initial Registration Statement required to be filed pursuant to Section 2(a), the 90th
calendar day following the Closing Date; provided, however, that if the Filing Deadline falls on a Saturday, Sunday
or other day that the Commission is closed for business, the Filing Deadline shall be extended to the next business day on which
the Commission is open for business.

 

“Holder” or “Holders”
means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified Party”
has the meaning set forth in Section 5(c).

 

    B-1 

    

    

 

“Indemnifying Party”
has the meaning set forth in Section 5(c).

 

“Initial Registration Statement”
means the initial Registration Statement filed pursuant to Section 2(a) of this Agreement.

 

“Inspector” or
“Inspectors” has the meaning set forth in Section 3(k).

 

“Liquidated Damages”
has the meaning set forth in Section 2(c).

 

“Losses” has
the meaning set forth in Section 5(a).

 

“New Registration Statement”
has the meaning set forth in Section 2(a).

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the
Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.

 

“Purchase Agreement”
has the meaning set forth in the Recitals.

 

“Purchaser” or
“Purchasers” has the meaning set forth in the Recitals.

 

“Records” has
the meaning set forth in Section 3(k).

 

“Registrable Securities”
means all of the Shares and any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization
or similar event with respect to the Shares, provided, that with respect to a particular Holder, such Holder’s Shares
shall cease to be Registrable Securities upon the earliest to occur of the following: (A) a sale pursuant to a Registration Statement
or Rule 144 under the Securities Act (in which case, only such security sold by the Holder shall cease to be a Registrable Security);
(B) becoming eligible for resale by the Holder under Rule 144 without the requirement for the Company to be in compliance
with the current public information requirement thereunder and without volume or manner-of-sale restrictions, pursuant to a written
opinion letter of counsel for the Company to such effect, addressed, delivered and acceptable to the Transfer Agent; or (C) the
date that is three years following the Closing Date.

 

“Registration Statements”
means any one or more registration statements of the Company filed under the Securities Act that covers the resale of any of the
Registrable Securities pursuant to the provisions of this Agreement (including, without limitation, the Initial Registration Statement,
the New Registration Statement and any Remainder Registration Statements), including (in each case) the amendments and supplements
to such Registration Statements, including pre- and post-effective amendments thereto, all exhibits and all material incorporated
by reference or deemed to be incorporated by reference in such Registration Statements.

 

“Remainder Registration Statements”
has the meaning set forth in Section 2(a).

 

“Rule 144” means
Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

    B-2 

    

    

 

“Rule 415” means
Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule 424” means
Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“SEC Guidance”
means (i) any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff, provided,
that any such oral guidance, comments, requirements or requests are reduced to writing by the Commission and (ii) the Securities
Act.

 

“Securities Act”
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Selling Stockholder Questionnaire”
means a questionnaire in the form attached as Annex B hereto, or such other form of questionnaire as may reasonably be adopted
by the Company from time to time.

 

“Shares” means
the shares of Common Stock issued or issuable to the Purchasers pursuant to the Purchase Agreement.

 

2.             Registration.

 

(a)           On or prior to the Filing Deadline, the Company shall prepare and file with the Commission a Registration Statement covering
the resale of all of the Registrable Securities not already covered by an existing and effective Registration Statement for an
offering to be made on a continuous basis pursuant to Rule 415 (the “Initial Registration Statement”).
The Initial Registration Statement shall be on Form S-3 (except that if the Company is then ineligible to register for resale the
Registrable Securities on Form S-3, in which case such registration shall be on such other form available to register for resale
the Registrable Securities as a secondary offering) subject to the provisions of Section 2(e) and shall contain (except if otherwise
required pursuant to written comments received from the Commission upon a review of such Registration Statement) a “Plan
of Distribution” section substantially in the form attached hereto as Annex A (which may be modified to respond to
comments, if any, provided by the Commission).

 

(i)                
Notwithstanding the registration obligations set forth in this Section 2, in the event the Commission informs the
Company that all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as
a secondary offering on a single registration statement or that any Holder must be named as an underwriter in the Registration
Statement, the Company agrees to promptly (x) inform each of the Holders thereof and use its commercially reasonable efforts to
file amendments to the Initial Registration Statement as required by the Commission and/or (y) withdraw the Initial Registration
Statement and file a new registration statement (a “New Registration Statement”), in either case covering
the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or such other form
available to register for resale the Registrable Securities as a secondary offering; provided, however, that prior to filing
such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate
with the Commission for the registration of all of the Registrable Securities in accordance with SEC Guidance, including without
limitation, Compliance and Disclosure Interpretation 612.09, in each case without naming any Holder as an underwriter in the Registration
Statement. Each Purchaser shall have the right to comment or have their counsel
comment on any written submission made to the staff of Commission (the “Staff”) with respect to any disclosure
specifically relating to such Purchaser. No such written submission shall be made to the Staff containing disclosure specifically
relating to such Purchaser to which such Purchaser’s counsel reasonably objects.

 

    B-3 

    

    

 

(ii)              
Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages in Section 2(c),
if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on a particular
Registration Statement as a secondary offering without naming any Holder as an underwriter (and notwithstanding that the Company
used commercially reasonable efforts to advocate with the Commission for the registration of all or a greater number of Registrable
Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the Registrable Securities to be
registered on such Registration Statement will be reduced (applied, in the case that some Shares may be registered, to the Holders
on a pro rata basis based on the total number of unregistered Shares held by such Holders), subject to a determination by the Commission
that certain Holders must be reduced first based on the number of Registrable Securities held by such Holders. Any reduction of
Registrable Securities pursuant to this Section 2(a)(ii) shall occur only after all securities that are not Registrable
Securities, if any, are first removed from such Registration Statement. In the event the Company amends the Initial Registration
Statement or files a New Registration Statement, as the case may be, under clauses (x) or (y) above, the Company will use its commercially
reasonable efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or
to registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register
for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended,
or the New Registration Statement (the “Remainder Registration Statements”). No Holder shall be named
as an “underwriter” in any Registration Statement without such Holder’s prior written consent.

 

(b)           
The Company shall use its commercially reasonable efforts to cause each Registration Statement to be declared effective
by the Commission as soon as practicable and, with respect to the Initial Registration Statement or the New Registration Statement,
as applicable, no later than the Effectiveness Deadline (including, with respect to the Initial Registration Statement or the New
Registration Statement, as applicable, filing with the Commission a request for acceleration of effectiveness in accordance with
Rule 461 promulgated under the Securities Act within five Business Days after the date that the Company is notified (orally or
in writing, whichever is earlier) by the Commission that such Registration Statement will not be “reviewed,” or not
be subject to further review and the effectiveness of such Registration Statement may be accelerated), and, subject to Section
2(e), shall use its commercially reasonable efforts to keep each Registration Statement continuously effective under the Securities
Act for so long as the securities registered for resale thereunder retain their character as “Registrable Securities”
(the “Effectiveness Period”). The Company shall promptly notify the Holders via facsimile or electronic
mail of the effectiveness of a Registration Statement or any post-effective amendment thereto on or before the first Trading Day
after the date that the Company telephonically confirms effectiveness with the Commission. The Company shall, by 9:30 a.m. Boston
time on the first Trading Day after the Effective Date, file a final Prospectus with the Commission, as required by Rule 424(b).

 

    B-4 

    

    

 

(c)            
If: (i) the Initial Registration Statement is not filed with the Commission on or prior to the Filing Deadline, (ii) the
Initial Registration Statement or the New Registration Statement, as applicable, is not declared effective by the Commission (or
otherwise does not become effective) for any reason on or prior to the Effectiveness Deadline or (iii) after its Effective Date
and except for the reasons as set forth in Section 3(h), (A) such Registration Statement ceases for any reason (including,
without limitation, by reason of a stop order or the Company’s failure to update the Registration Statement), to remain continuously
effective as to all Registrable Securities included in such Registration Statement or (B) the Holders are not permitted to utilize
the Prospectus therein to resell such Registrable Securities for any reason (other than due to a change in the “Plan of Distribution”
or the inaccuracy of any information regarding the Holders), in each case, for more than an aggregate of 45 calendar days
(which need not be consecutive days) during any 12-month period (other than as a result of a material breach of this Agreement
by a Holder or a Holder’s failure to return a Selling Stockholder Questionnaire within the time period provided by Section
2(d) hereof) (any such failure or breach in clauses (i) through (iii) above being referred to as an “Event,”
and, for purposes of clauses (i) or (ii), the date on which such Event occurs, or for purposes of clause (iii), the date on which
such 45 calendar day period is exceeded, being referred to as an “Event Date”), then in addition to any
other rights the Holders may have hereunder or under applicable law: (x) within five Business Days after an Event Date relating
to a failure in clause (i) only, the Company shall pay to each Holder an amount in cash, as liquidated damages and not as a penalty,
equal to 1.0% of the aggregate purchase price paid by such Holder pursuant to the Purchase Agreement for any Registrable Securities
held by such Holder on such Event Date; and (y) on each 30-day anniversary (or pro rata portion thereof) following any Event Date
(including, for the avoidance of doubt, a failure in clause (i), in which case each 30-day anniversary shall be measured commencing
on the 31st day following such Event Date) until the earlier of (1) the applicable Event is cured or (2) the Registrable
Securities are eligible for resale pursuant to Rule 144 without manner of sale or volume restrictions, the Company shall pay
to each Holder an amount in cash, as liquidated damages and not as a penalty, equal to 1.0% of the aggregate purchase price paid
by such Holder pursuant to the Purchase Agreement for any unregistered Registrable Securities then held by such Holder. The amounts
payable pursuant to the foregoing clauses (x) and (y) are referred to collectively as “Liquidated Damages.”
The parties agree that (1) notwithstanding anything to the contrary herein or in the Purchase Agreement, no Liquidated Damages
shall be payable with respect to any period after the expiration of the Effectiveness Period and in no event shall the aggregate
amount of Liquidated Damages payable to a Holder exceed, in the aggregate, 6.0% of the aggregate purchase price paid by such Holder
pursuant to the Purchase Agreement and (2) in no event shall the Company be liable in any 30-day period for Liquidated Damages
under this Agreement in excess of 1.0% of the aggregate purchase price paid by the Holders pursuant to the Purchase Agreement.
If the Company fails to pay any Liquidated Damages pursuant to this Section 2(c) in full within 30 Business Days after the date
payable, the Company will pay interest thereon at a rate of 1.0% per month (or such lesser maximum amount that is permitted to
be paid by applicable law) to the Holder, accruing daily from the date such Liquidated Damages are due until such amounts, plus
all such interest thereon, are paid in full. Unless otherwise specified in Section 2(c), the Liquidated Damages pursuant to the
terms hereof shall apply on a daily pro-rata basis for any portion of a month prior to the cure of an Event, except in the case
of the first Event Date. Notwithstanding the foregoing, nothing shall preclude any Holder from pursuing or obtaining any available
remedies at law, specific performance or other equitable relief with respect to this Section 2(c) in accordance with applicable
law. The Company shall not be liable for Liquidated Damages under this Agreement as to any Registrable Securities which may then
be resold under Rule 144 or which are not permitted by the Commission to be included in a Registration Statement due solely to
SEC Guidance from the time that it is determined that such Registrable Securities are not permitted to be registered until such
time as the provisions of this Agreement as to the Remainder Registration Statements required to be filed hereunder are triggered,
in which case the provisions of this Section 2(c) shall once again apply, if applicable. In such case, the Liquidated Damages shall
be calculated to only apply to the percentage of Registrable Securities which are permitted in accordance with SEC Guidance to
be included in such Registration Statement. The Effectiveness Deadline for a Registration Statement shall be extended without default
or Liquidated Damages hereunder in the event that the Company’s failure to obtain the effectiveness of the Registration Statement
on a timely basis results from the failure of a Holder to timely provide the Company with information requested by the Company
and necessary to complete the Registration Statement in accordance with the requirements of the Securities Act (in which the Effectiveness
Deadline would be extended with respect to Registrable Securities held by such Holder).

 

    B-5 

    

    

 

(d)             
Each Holder agrees to furnish to the Company a completed Selling Stockholder Questionnaire not more than ten Trading Days
following the date of this Agreement. At least five Trading Days prior to the first anticipated filing date of a Registration Statement
for any registration under this Agreement, the Company will notify each Holder of the information the Company requires from that
Holder other than the information contained in the Selling Stockholder Questionnaire, if any, which shall be completed and delivered
to the Company promptly upon request and, in any event, within two Trading Days prior to the applicable anticipated filing date.
Each Holder further agrees that it shall not be entitled to be named as a selling security holder in the Registration Statement
or use the Prospectus for offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company
a completed and signed Selling Stockholder Questionnaire and a response to any reasonable requests for further information as described
in the previous sentence. If a Holder of Registrable Securities returns a Selling Stockholder Questionnaire or a request for further
information, in either case, after its respective deadline, the Company shall use its commercially reasonable efforts to take such
actions as are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective or
post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the Registrable
Securities identified in such late Selling Stockholder Questionnaire or request for further information. Each Holder acknowledges
and agrees that the information in the Selling Stockholder Questionnaire or request for further information as described in this
Section 2(d) will be used by the Company in the preparation of the Registration Statement and hereby consents to the inclusion
of such information in the Registration Statement.

 

(e)              
In the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the
Company shall (i) register the resale of the Registrable Securities on Form S-1 and (ii) undertake to register the Registrable
Securities on Form S-3 promptly after such form is available, provided that the Company shall maintain the effectiveness of the
Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities
has been declared effective by the Commission.

 

3.           
Registration Procedures.

 

In connection with the Company’s
registration obligations hereunder, the Company shall:

 

(a)              
Not less than three Trading Days prior to the filing of each Registration Statement and not less than two Trading Days
prior to the filing of any related Prospectus or any amendment or supplement thereto (except for Annual Reports on Form 10-K,
and Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and any similar or successor reports), (i) furnish to the Holder
copies of such Registration Statement, Prospectus or amendment or supplement thereto, substantially in the form as proposed to
be filed, which documents will be subject to the review of such Holder (it being acknowledged and agreed that if a Holder does
not object to or comment on the aforementioned documents within such three Trading Day or two Trading Day period, as the case
may be, then the Holder shall be deemed to have consented to and approved the use of such documents) and (ii) use commercially
reasonable efforts to cause its officers and directors, counsel and independent registered public accountants to respond to such
inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct such review. The Company
shall not file any Registration Statement or Prospectus or any amendment or supplement thereto in a form to which a Holder reasonably
objects in good faith, provided that, the Company is notified of such objection in writing within the three Trading Day
or two Trading Day period described above, as applicable, and provided further, that no such delay in filing
shall result in any Liquidated Damages under Section 2(c).

 

    B-6 

    

    

 

(b)             
(i) Subject to Section 3(h), prepare and file with the Commission such amendments (including post-effective amendments)
and supplements to each Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such
Registration Statement continuously effective as to the applicable Registrable Securities for its Effectiveness Period; (ii) cause
the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement),
and, as so supplemented or amended, to be filed pursuant to Rule 424; (iii) respond as promptly as reasonably practicable to any
comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly as
reasonably possible, provide the Holders true and complete copies of all correspondence from and to the Commission relating to
such Registration Statement that pertains to the Holders as “Selling Stockholders” but not any comments that would
result in the disclosure to the Holders of material and non-public information concerning the Company; and (iv) comply with the
provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by
a Registration Statement until such time as all of such Registrable Securities cease to be Registrable Securities or shall have
been disposed of (subject to the terms of this Agreement) in accordance with the intended methods of disposition by the Holders
thereof as set forth in such Registration Statement as so amended or in such Prospectus as so supplemented; provided,
however, that in the event the Company informs the Holders in writing that it does not satisfy the conditions specified
in Rule 172 and, as a result thereof, the Holders are required to deliver a Prospectus in connection with any disposition of Registrable
Securities, the Company shall deliver to the Holders a copy of the Prospectus in electronic format and each such Holder shall
be responsible for the delivery of the Prospectus to the Persons to whom such Holder sells any of the Registrable Securities,
and each Holder agrees to dispose of Registrable Securities in compliance with the “Plan of Distribution” described
in the Registration Statement and otherwise in compliance with applicable federal and state securities laws. In the case of amendments
and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant to this
Section 3(b)) by reason of the Company filing a report on Form 10-K, Form 10-Q or Form 8-K or any analogous report
under the Exchange Act, the Company shall have incorporated such report by reference into such Registration Statement, if applicable,
or shall file such amendments or supplements with the Commission on the same day on which the Exchange Act report which created
the requirement for the Company to amend or supplement such Registration Statement was filed.

 

(c)              
Notify the Holders (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction
to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably practicable via facsimile
or electronic mail (and, in the case of (i)(A) below, not less than two Trading Days prior to such filing) and no later than two
Trading Days following the day: (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration
Statement is proposed to be filed; (B) when the Commission notifies the Company whether there will be a “review” of
such Registration Statement and whenever the Commission comments in writing on any Registration Statement (in which case the Company
shall provide to each of the Holders true and complete copies of all comments that pertain to the Holders as a “Selling
Stockholder” or to the “Plan of Distribution” and all written responses thereto, but not information that the
Company believes would constitute material and non-public information); and (C) with respect to each Registration Statement
or any post-effective amendment thereto, when the same has become effective; (ii) of any request by the Commission or any other
Federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information that pertains to the Holders as “Selling Stockholders” or the “Plan of Distribution”; (iii)
of the issuance by the Commission or any other Federal or state governmental authority of any stop order suspending the effectiveness
of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose;
(iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification
of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such
purpose; (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in such Registration Statement or Prospectus or any document
incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to
such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or the Prospectus,
as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to
be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of prospectus or supplement
thereto, in light of the circumstances under which they were made), not misleading; and (vi) of the occurrence or existence of,
or in anticipation of, any acquisition, financing activity, regulatory developments or other material transaction involving the
Company, or any other event or condition of similar significance to the Company, for which allowing the continued availability
of a Registration Statement or Prospectus would be, in the good faith determination of the Board of Directors, materially detrimental
to the Company, provided that, any and all such information shall remain confidential to each Holder until such information
otherwise becomes public, unless disclosure by a Holder is required by law; and provided further, that notwithstanding
each Holder’s agreement to keep such information confidential, each such Holder makes no acknowledgement that any such information
is material, non-public information.

 

    B-7 

    

    

 

(d)             
Use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order suspending
the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of
any of the Registrable Securities for sale in any jurisdiction, as soon as practicable.

 

(e)              
If requested by a Holder, furnish to such Holder, without charge, at least one conformed copy of each Registration Statement
and each amendment thereto and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission; provided, that the Company shall have no
obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system.

 

(f)              
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify
or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration
or qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions
within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption
therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable
the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that
the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, would
subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service
of process in any such jurisdiction.

 

(g)              
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates or
book-entry statements representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement,
which certificates or book entry statements shall be free, to the extent permitted by the Purchase Agreement, and under law, of
all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as
any such Holders may reasonably request.

 

(h)             
Following the occurrence of any event contemplated by Section 3(c), as promptly as reasonably practicable (taking
into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature
disclosure of such event), prepare a supplement or amendment, including a post-effective amendment, to the affected Registration
Statements or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference,
and file any other required document so that, as thereafter delivered, no Registration Statement nor any Prospectus will contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the circumstances under
which they were made), not misleading. If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section
3(c) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders
shall suspend use of such Prospectus. The Company will use its commercially reasonable efforts to ensure that the use of the Prospectus
may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(h)
to suspend the availability of a Registration Statement and Prospectus for a period not to exceed 45 calendar days (which need
not be consecutive days) in any 12-month period without incurring liability for Liquidated Damages otherwise required pursuant
to Section 2(c).

 

    B-8 

    

    

 

(i)               
The Company may require each selling Holder to furnish to the Company a certified statement as to (i) the number of shares
of Common Stock beneficially owned by such Holder and any Affiliate thereof, (ii) any Financial Industry Regulatory Authority,
Inc. (“FINRA”) affiliations, (iii) any natural persons who have the power to vote or dispose of
the common stock and (iv) any other information as may be requested by the Commission, FINRA or any state securities commission.
During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of Registrable
Securities because any Holder fails to furnish such information within three Trading Days of the Company’s request, any Liquidated
Damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because
of such delay shall be suspended as to such Holder only, until such information is delivered to the Company; provided, however,
if the failure of the Holder to furnish the required information results the occurrence of an Event under 2(c), any Liquidated
Damages that are accruing at such time shall be tolled and any such Event that occurs as a result thereof shall be suspended until
such time as the Holder furnishes such information.

 

(j)               
The Company shall cooperate with any registered broker through which a Holder proposes to resell its Registrable Securities
in effecting a filing with FINRA pursuant to FINRA Rule 5110 as reasonably requested by any such Holder, and the Company shall
pay the filing fee required for the first such filing within five Business Days of the request therefor.

 

(k)             
Cause all such Registrable Securities to be listed on each securities exchange on which similar securities issued by the
Company are then listed.

 

4.            
Registration Expenses. All fees and expenses incident to the Company’s performance of or compliance with its
obligations under this Agreement (excluding any underwriting discounts and selling commissions and all legal fees and expenses
of legal counsel for any Holder) shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a
Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all
registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made
with any Trading Market on which the Common Stock is then listed for trading, (B) with respect to compliance with applicable state
securities or Blue Sky laws (including, without limitation, fees and disbursements of counsel for the Company in connection with
Blue Sky qualifications or exemptions of the Registrable Securities and determination of the eligibility of the Registrable Securities
for investment under the laws of such jurisdictions as requested by the Holders, but not including any jurisdictions outside the
United States) and (C) if not previously paid by the Company pursuant to Section 3(j) hereof, with respect to any filing that may
be required to be made by any broker through which a Holder intends to make sales of Registrable Securities with FINRA pursuant
to FINRA Rule 5110), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities
and of printing prospectuses if the printing of prospectuses is reasonably requested by the Holders of a majority of the Registrable
Securities included in the Registration Statement), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements
of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and
expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this
Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation
of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and
employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection
with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company
be responsible for any underwriting, broker or similar fees or commissions of any Holder or any legal fees or other costs of the
Holders.

 

    B-9 

    

    

 

5.            
Indemnification.

 

(a)              
Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and
hold harmless each Holder, the officers, directors, agents, partners, members, managers, stockholders, Affiliates and employees
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) and the officers, directors, partners, members, managers, stockholders, agents and employees of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
amounts paid in settlement in accordance with Section 5(c) hereof, costs (including, without limitation, reasonable costs
of preparation and investigation and reasonable attorneys’ fees) and expenses (collectively, “Losses”),
as incurred, that arise out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in any
Registration Statement, any Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved
Annex A hereto for this purpose), or arising out of or relating to any omission or alleged omission to state a material
fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto,
in light of the circumstances under which they were made) not misleading or (ii) any violation or alleged violation by the Company
of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder relating to the offer
or sale of the Registrable Securities pursuant to the Registration Statement, except to the extent, but only to the extent that
(A) such untrue statements, alleged untrue statements, omissions or alleged omissions are based solely upon information regarding
such Holder furnished in writing to the Company by such Holder, or to the extent that such information relates to such Holder or
such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such
Holder expressly for use in the Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood
that each Holder has approved Annex A hereto for this purpose); provided, that such untrue statement or alleged untrue statement
or omission or alleged omission had not been corrected in such Prospectus or in any amendment or supplement thereto prior to, or
concurrently with, the sale of Registrable Securities to the person asserting the applicable indemnification claim, or (B) in the
case of an occurrence of an event of the type specified in Section 3(c)(iii)-(vi), related to the use by a Holder
of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or
defective and prior to the receipt by such Holder of the Advice contemplated and defined in Section 6(d) below, following
the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected, or (C) any such Losses
arise out of the Purchaser’s (or any other indemnified Person’s) failure to send or give a copy of the Prospectus or
supplement (as then amended or supplemented), if required pursuant to Rule 172 under the Securities Act (or any successor rule),
to the Persons asserting an untrue statement or alleged untrue statement or alleged untrue statement or omission or alleged omission
at or prior to the written confirmation of the sale of Registrable Securities to such Person if such statement or omission was
corrected in such Prospectus or supplement. The Company shall notify the Holders promptly of the institution, threat or assertion
of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware.
Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of an Indemnified Party
(as defined in Section 5(c)) and shall survive the transfer of the Registrable Securities by the Holders.

 

    B-10 

    

    

 

(b)             
Indemnification by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company,
its directors, officers, agents, stockholders, Affiliates and employees, each Person who controls the Company (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such
controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of
or are based solely upon any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any
Prospectus, or in any amendment or supplement thereto, or arising out of or relating to any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, or supplement thereto,
in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue
statements or omissions are based upon information regarding such Holder furnished in writing to the Company by such Holder expressly
for use therein and such untrue statement or alleged untrue statement or omission or alleged omission had not been corrected in
such Prospectus or in any amendment or supplement thereto prior to, or concurrently with, the sale of Registrable Securities to
the person asserting the applicable indemnification claim, or (ii) to the extent that such information relates to such Holder or
such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such
Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for
this purpose), such Prospectus or in any amendment or supplement thereto or (iii) in the case of an occurrence of an event of the
type specified in Section 3(c)(iii)-(vi), to the extent, but only to the extent, related to the use by such Holder
of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or
defective and prior to the receipt by such Holder of the Advice contemplated in Section 6(d). In no event shall the liability
of any selling Holder hereunder (together with any liability under Section 5(d)) be greater in amount than the dollar
amount of the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification
obligation.

 

(c)              
Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled
to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person
from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall
have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party
and the payment of all reasonable fees and expenses incurred in connection with defense thereof, provided, that the failure
of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant
to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which
determination is not subject to appeal or further review) that such failure shall have materially and adversely prejudiced the
Indemnifying Party.

 

An Indemnified Party shall have the right
to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses of such
counsel shall be at the expense of such Indemnified Party or Parties unless: (i) the Indemnifying Party has agreed in writing to
pay such fees and expenses; (ii) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding or
the Indemnifying Party does not, upon assuming the defense of such Proceeding, conduct the defense of such claim actively and diligently;
(iii) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying
Party, and such Indemnified Party shall have been advised by counsel that a conflict of interest exists if the same counsel were
to represent such Indemnified Party and the Indemnifying Party; (iv) the claim is based upon any Proceeding, indictment, allegation
or investigation of a criminal nature; or (v) the claim seeks an injunction or non-monetary or equitable relief against the Indemnified
Party, other than any such claim that is incidental to the primary claim or claims and not material (in the case of clauses (ii)-(v),
if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of
the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and such counsel shall be
at the expense of the Indemnifying Party); provided, that the Indemnifying Party shall not be liable for the fees and expenses
of more than one separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying Party shall not be liable
for any settlement of any such Proceeding effected without its prior written consent, which consent shall not be unreasonably withheld,
delayed or conditioned. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement
of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional
release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding and such settlement
does not require any Indemnified Party to perform any covenant or refrain from engaging in any activity or include any non-monetary
limitation on the actions of any Indemnified Party or any of its affiliates or any admission of fault, violation, culpability,
malfeasance or nonfeasance by, or on behalf of, or liability on behalf of, any such Indemnified Party.

 

    B-11 

    

    

 

Subject to the terms of this Agreement,
all fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with
investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section 5) shall be paid to the Indemnified
Party, as incurred, within 20 Trading Days of written notice thereof to the Indemnifying Party; provided, that the Indemnified
Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for
which such Indemnified Party is finally judicially determined to not be entitled to indemnification hereunder. The failure to deliver
written notice to the Indemnifying Party within a reasonable time of the commencement of any such action shall not relieve such
Indemnifying Party of any liability to the Indemnified Party under this Section 5, except to the extent that the Indemnifying Party
is materially and adversely prejudiced in its ability to defend such action.

 

(d)             
Contribution. If a claim for indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified
Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party, in lieu of indemnifying
such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in
such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with
the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action
in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The
amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in
this Agreement, any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with
any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for
in this Section 5 was available to such party in accordance with its terms.

 

The parties hereto agree that it would
not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any
other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. Notwithstanding the provisions of this Section 5(d), (A) no Holder shall be required to contribute, in the aggregate,
any amount in excess of the amount by which the net proceeds actually received by such Holder from the sale of the Registrable
Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason
of such untrue or alleged untrue statement or omission or alleged omission, including pursuant to Section 5(b) above, and
(B) no contribution will be made under circumstances where the maker of such contribution would not have been required to indemnify
the Indemnified Party under the fault standards set forth in this Section 5. No person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation.

 

    B-12 

    

    

 

6.            
Rule 144 Compliance. With a view to making available to the Holders the benefits of Rule 144 under the Securities
Act and any other rule or regulation of the Commission that may at any time permit a Holder to sell securities of the Company to
the public without registration, the Company shall:

 

(i)               use commercially reasonable efforts to make and keep public information available, as those terms are understood and defined
in Rule 144 under the Securities Act;

 

(ii)              use commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required
of the Company under the Exchange Act, at any time when the Company is subject to such reporting requirements; and

 

(iii)            
furnish to any Holder, promptly upon request, a written statement by the Company as to its compliance with the reporting
requirements of Rule 144 under the Securities Act and of the Exchange Act, a copy of the most recent annual or quarterly report
of the Company, and such other reports and documents so filed or furnished by the Company with the Commission as such Holder may
reasonably request in connection with the sale of Registrable Securities without registration (in each case to the extent not readily
publicly available).

 

7.          
  Miscellaneous.

 

(a)              
Remedies. The Company and each Holder agree that monetary damages may not provide adequate compensation for any losses
incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, subject to the
limitations set forth elsewhere in this Agreement, in the event of a breach by the Company or by a Holder of any of their obligations
under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted
by law and under this Agreement, including recovery of damages, may be entitled to specific performance of its rights under this
Agreement.

 

(b)             
Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the
Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities
pursuant to the Registration Statement, and shall sell the Registrable Securities only in accordance with a method of distribution
described in the Registration Statement

 

(c)              
Discontinued Disposition. By its acquisition of Registrable Securities, the Holder agrees that, upon receipt of a
notice from the Company of the occurrence of any event of the kind described in Section 3(c)(iii)-(vi), such Holder
will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing
(the “Advice”) by the Company that the use of the applicable Prospectus (as it may have been supplemented
or amended) may be resumed. The Company will use its commercially reasonable efforts to ensure that the use of the Prospectus may
be resumed as promptly as is practicable. The Company may provide appropriate stop orders to enforce the provisions of this paragraph.

 

(d)             
No Inconsistent Agreements. The Company has not entered, as of the date hereof, nor shall the Company, on or after
the date hereof, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted
to the Holders in this Agreement or otherwise conflicts with the provisions hereof.

 

    B-13 

    

    

 

(e)              
Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, or waived unless the same shall be in writing and signed by the Company and Holders holding no less that
a majority of the then outstanding Registrable Securities or, if such amendment, modification or supplement shall affect a Holder
in a manner disproportionate from other Holders then the signature of such Holder shall be required, provided that any party
may give a waiver as to itself. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect
to a matter that relates exclusively to the rights of Holders and that does not directly or indirectly affect the rights of other
Holders may be given by Holders of all of the Registrable Securities to which such waiver or consent relates; provided,
however, that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the
provisions of the immediately preceding sentence.

 

(f)              
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be delivered as set forth in the Purchase Agreement.

 

(g)              
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted
assigns of each of the parties and shall inure to the benefit of each Holder. Nothing in this Agreement, express or implied, is
intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. The Company may
not assign its rights (except by merger or in connection with another entity acquiring all or substantially all of the Company’s
assets) or obligations hereunder without the prior written consent of all the Holders of the then outstanding Registrable Securities.
Each Holder may assign its respective rights hereunder in the manner and to the Persons as permitted under the Purchase Agreement
provided in each case that (i) the Holder agrees in writing with the transferee or assignee to assign such rights and
related obligations under this Agreement, and for the transferee or assignee to assume such obligations, and a copy of such agreement
is furnished to the Company within a reasonable time after such assignment, (ii) the Company is, within a reasonable time
after such transfer or assignment, furnished with written notice of the name and address of such transferee or assignee and the
securities with respect to which such registration rights are being transferred or assigned, (iii) at or before the time the
Company received the written notice contemplated by clause (ii) of this sentence, the transferee or assignee agrees in writing
with the Company to be bound by all of the provisions contained herein and (iv) the transferee is an “accredited investor,”
as that term is defined in Rule 501 of Regulation D.

 

(h)             
Execution and Counterparts. This Agreement may be executed in two or more counterparts, each of which when so executed
shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties
need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature
were the original thereof.

 

(i)               
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be determined in accordance with the provisions of the Purchase Agreement.

 

(j)               
Cumulative Remedies. Except as provided herein, the remedies provided herein are cumulative and not exclusive of
any other remedies provided by law.

 

    B-14 

    

    

 

(k)             
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their good faith reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

(l)               
Headings. The headings in this Agreement are for convenience only and shall not limit or otherwise affect the meaning
hereof.

 

[Remainder of Page Intentionally Left
Blank; Signature Page Follows]

 

    B-15 

    

    

 

IN WITNESS WHEREOF, the parties have executed
this Registration Rights Agreement as of the date first written above.

 

	 	CORINDUS VASCULAR ROBOTICS, INC.
	 	 	 
	 	By:	        
	 	Name:
	 	Title:

 

[Signature Page to Registration Rights Agreement]

 

     

    

    

 

IN WITNESS WHEREOF, the parties have executed
this Registration Rights Agreement as of the date first written above.

 

	 	HOLDER:	 

 

	 	AUTHORIZED SIGNATORY
	 	 	 
	 	By:	        
	 	 	Name:
	 	 	Title:

 

	 	ADDRESS FOR NOTICE

	 	 	 
	 	c/o: 	 

 

	 	Street: 	 

 

	 	City/State/Zip:	 

 

	 	Attention: 	 

 

	 	Tel: 	 

 

	 	Fax: 	 

 

	 	Email: 	 

 

[Signature Page to Registration Rights Agreement]

 

     

    

    

 

Annex A

 

PLAN OF DISTRIBUTION

 

The selling stockholders and any of their
pledgees, donees, transferees, assignees or other successors-in-interest may, from time to time, sell, transfer or otherwise dispose
of any or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading
facility on which the shares are traded or in private transactions.  These dispositions may be at fixed prices, at prevailing
market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time
of sale, or at negotiated prices.  The selling stockholders may use one or more of the following
methods when disposing of the shares or interests therein:

 

		●	ordinary
                                         brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

		●	block
                                         trades in which the broker-dealer will attempt to sell the shares as agent but may position
                                         and resell a portion of the block as principal to facilitate the transaction;

 

		●	through
                                         brokers, dealers or underwriters that may act solely as agents;

 

		●	purchases
                                         by a broker-dealer as principal and resale by the broker-dealer for its account;

 

		●	an
                                         exchange distribution in accordance with the rules of the applicable exchange;

 

		●	privately
                                         negotiated transactions;

 

		●	through
                                         the writing or settlement of options or other hedging transactions entered into after
                                         the effective date of the registration statement of which this prospectus is a part,
                                         whether through an options exchange or otherwise;

 

		●	broker-dealers
                                         may agree with the selling stockholder to sell a specified number of such shares at a
                                         stipulated price per share;

 

		●	one
                                         or more underwritten offerings on a firm commitment or best efforts basis;

 

		●	a
                                         combination of any such methods of disposition; and

 

		●	any
                                         other method permitted pursuant to applicable law.

 

The
selling stockholders may also sell shares under Rule 144 under the Securities Act of 1933, as amended, or Securities
Act, if available, rather than under this prospectus.

 

Broker-dealers engaged by the selling stockholders
may arrange for other broker-dealers to participate in sales.  Broker-dealers may receive commissions or discounts from the
selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be
negotiated.  The selling stockholders do not expect these commissions and discounts to exceed what is customary in the types
of transactions involved.

 

    Annex A-1 

    

    

 

The selling stockholders may from time to
time pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the
performance of their secured obligations, the pledgees or secured parties may offer and sell shares of common stock from time to
time under this prospectus, or under a supplement or amendment to this prospectus under Rule 424(b)(3) or other applicable
provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other successors
in interest as selling stockholders under this prospectus.

 

Upon being notified in writing by a selling
stockholder that any material arrangement has been entered into with a broker-dealer for the sale of common stock through a block
trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer, we will file a supplement
to this prospectus, if required, pursuant to Rule 424(b) under the Securities Act, disclosing (i) the name of such
selling stockholder and of the participating broker-dealer(s), (ii) the number of shares involved, (iii) the price at
which such shares of common stock were sold, (iv) the commissions paid or discounts or concessions allowed to such broker-dealer(s),
where applicable, (v) that such broker-dealer(s) did not conduct any investigation to verify the information set out
or incorporated by reference in this prospectus, and (vi) other facts material to the transaction.  In addition, upon
being notified in writing by the selling stockholder that a donee or pledge intends to sell more than 500 shares of common stock,
we will file a supplement to this prospectus if then required in accordance with applicable securities law.

 

The selling stockholders also may transfer
the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will
be the selling beneficial owners for purposes of this prospectus.

 

In connection with the sale of the shares
of common stock or interests in shares of common stock, the selling stockholders may enter into hedging transactions after the
effective date of the registration statement of which this prospectus is a part with broker-dealers or other financial institutions,
which may in turn engage in short sales of the common stock in the course of hedging the positions they assume.  The selling
stockholders may also sell shares of common stock short after the effective date of the registration statement of which this prospectus
is a part and deliver these securities to close out their short positions, or loan or pledge the common stock to broker-dealers
that in turn may sell these securities.  The selling stockholders may also enter into option or other transactions after the
effective date of the registration statement of which this prospectus is a part with broker-dealers or other financial institutions
or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution
of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this
prospectus (as supplemented or amended to reflect such transaction).

 

The selling stockholders and any broker-dealers
or agents that are involved in selling the shares may be deemed to be “underwriters” within the meaning of the Securities
Act in connection with such sales.  In such event, any commissions received by such broker-dealers or agents and any profit
on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. 

 

We have advised the selling stockholders
that they are required to comply with Regulation M promulgated under the Securities Exchange Act during such time as it may be
engaged in a distribution of the shares.  The foregoing may affect the marketability of the common stock.

 

The aggregate proceeds to the selling stockholders
from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions,
if any.  The selling stockholders reserve the right to accept and, together with their agents from time to time, to reject,
in whole or in part, any proposed purchase of common stock to be made directly or through agents.  We will not receive any
of the proceeds from this offering.

 

    Annex A-2 

    

    

 

We are required to pay all fees and expenses
incident to the registration of the shares.  We have agreed to indemnify the selling stockholders against certain losses,
claims, damages and liabilities, including liabilities under the Securities Act or otherwise.

 

We have agreed with the selling stockholders
to keep the registration statement of which this prospectus constitutes a part effective until the earlier of (a) such time
as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with the registration statement,
and (b) the date on which the shares of common stock covered by this prospectus may be sold by non-affiliates without any
volume or manner of sale restrictions or current public information pursuant to Rule 144 of the Securities Act.

 

    Annex A-3 

    

    

 

Annex B

 

CORINDUS VASCULAR ROBOTICS, INC.

 

SELLING STOCKHOLDER NOTICE AND QUESTIONNAIRE

 

The undersigned holder of shares of the
common stock, par value $0.0001 per share, of Corindus Vascular Robotics, Inc. (the “Company”) understands
that the Company intends to file with the Securities and Exchange Commission a registration statement on Form S-3, or if Form S-3
is not available, Form S-1 (the “Resale Registration Statement”) for the registration and the
resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable
Securities in accordance with the terms of the Registration Rights Agreement. All capitalized terms not otherwise defined herein
shall have the meanings ascribed thereto in the Registration Rights Agreement.

 

In order to sell or otherwise dispose of
any Registrable Securities pursuant to the Resale Registration Statement, a holder of Registrable Securities generally will be
required to be named as a selling stockholder in the related prospectus or a supplement thereto (as so supplemented, the “Prospectus”),
deliver the Prospectus to purchasers of Registrable Securities (including pursuant to Rule 172 under the Securities Act) and be
bound by the provisions of the Registration Rights Agreement (including certain indemnification provisions, as described below).
Holders must complete and deliver this Notice and Questionnaire in order to be named as selling stockholders in the Prospectus.

 

Certain legal consequences arise from being
named as a selling stockholder in the Resale Registration Statement and the Prospectus. Holders of Registrable Securities are advised
to consult their own securities law counsel regarding the consequences of being named or not named as a selling stockholder in
the Resale Registration Statement and the Prospectus.

 

NOTICE

 

The undersigned holder (the “Selling
Stockholder”) of Registrable Securities hereby gives notice to the Company of its intention to sell or otherwise
dispose of Registrable Securities owned by it and listed below in Item (3), unless otherwise specified in Item (3), pursuant to
the Resale Registration Statement. The undersigned, by signing and returning this Notice and Questionnaire, understands and agrees
that it will be bound by the terms and conditions of this Notice and Questionnaire and the Registration Rights Agreement.

 

The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate and complete:

 

 QUESTIONNAIRE

 

		1.	Name.

 

		(a)	Full Legal Name of Selling Stockholder:

 

____________________________

 

		(b)	Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities
Listed in Item 3 below are held:

 

____________________________

 

    Annex B-1 

    

    

 

		(c)	Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly
alone or with others has power to vote or dispose of the securities covered by the questionnaire):

 

____________________________

 

		2.	Address for Notices to Selling Stockholder:

 

	 
	 
	 

	Telephone:
	Fax:
	Contact Person:
	E-mail address of Contact Person:

 

		3.	Beneficial Ownership of Registrable Securities:

 

		(a)	Type and Number of Registrable Securities beneficially owned:

 

____________________________

 

____________________________

 

____________________________

 

		(b)	Number of shares of Common Stock to be registered pursuant to this Notice for resale:

 

____________________________

 

____________________________

 

____________________________

 

		4.	Broker-Dealer Status:

 

		(a)	Are you a broker-dealer?

 

Yes ☐       No ☐

 

		(b)	If “yes” to Section 4(a), did you receive your Registrable
Securities as compensation for investment banking services to the Company?

 

Yes ☐       No ☐

 

		Note:	If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

    Annex B-2 

    

    

 

		(c)	Are you an affiliate of a broker-dealer?

 

Yes ☐       No ☐

 

Note: If yes, provide
a narrative explanation below:

 

____________________________

 

____________________________

 

		(d)	If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course
of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings,
directly or indirectly, with any person to distribute the Registrable Securities?

 

Yes ☐       No ☐

 

		Note:	If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

		5.	Beneficial Ownership of Other Securities of the Company Owned by the Selling Stockholder.

 

Except as set forth below in this Item 5, the
undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities listed
above in Item 3.

 

Type and amount of other securities
beneficially owned:

 

	 	 
	 	 	 
	 	 
	 	 
	 	 	 

  

		6.	Relationships with the Company:

 

Except as set forth below, neither the undersigned
nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the
undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or
affiliates) during the past three years.

 

State any exceptions here:

 

	 	 
	 	 
	 	 
	 	 

 

		7.	Plan of Distribution:

 

The undersigned has reviewed the form of Plan
of Distribution attached as Annex A to the Registration Rights Agreement, and hereby confirms that, except as set forth below,
the information contained therein regarding the undersigned and its plan of distribution is correct and complete.

 

    Annex B-3 

    

    

 

State any exceptions here:

	 	 
	 	 

 

The undersigned agrees to promptly notify
the Company of any inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof and
prior to the effective date of any applicable Resale Registration Statement. All notices hereunder and pursuant to the Registration
Rights Agreement shall be made in writing, by hand delivery, confirmed or facsimile transmission, first-class mail or air courier
guaranteeing overnight delivery at the address set forth below. In the absence of any such notification, the Company shall be entitled
to continue to rely on the accuracy of the information in this Notice and Questionnaire.

 

By signing below, the undersigned consents
to the disclosure of the information contained herein in its answers to Items (1) through (7) above and the inclusion of such information
in the Resale Registration Statement and the Prospectus. The undersigned understands that such information will be relied upon
by the Company in connection with the preparation or amendment of any such Registration Statement and the Prospectus.

 

By signing below, the undersigned acknowledges
that it understands its obligation to comply, and agrees that it will comply, with the provisions of the Exchange Act and the rules
and regulations thereunder, particularly Regulation M in connection with any offering of Registrable Securities pursuant to the
Resale Registration Statement. The undersigned also acknowledges that it understands that the answers to this Questionnaire are
furnished for use in connection with Registration Statements filed pursuant to the Registration Rights Agreement and any amendments
or supplements thereto filed with the Commission pursuant to the Securities Act.

 

The undersigned hereby
acknowledges and is advised of the following Interpretation A.65 of the July 1997 SEC Manual of Publicly Available Telephone Interpretations
regarding short selling:

 

“An Issuer filed a Form S-3 registration
statement for a secondary offering of common stock which is not yet effective. One of the selling stockholders wanted to do a short
sale of common stock “against the box” and cover the short sale with registered shares after the effective date. The
issuer was advised that the short sale could not be made before the registration statement become effective, because the shares
underlying the short sale are deemed to be sold at the time such sale is made. There would, therefore, be a violation of Section 5
if the shares were effectively sold prior to the effective date.”

 

By returning this Questionnaire, the undersigned
will be deemed to be aware of the foregoing interpretation.

 

I confirm that, to the best of my knowledge
and belief, the foregoing statements (including, without limitation the answers to this Questionnaire) are correct.

 

    Annex B-4 

    

    

 

IN WITNESS WHEREOF the undersigned, by authority
duly given, has caused this Questionnaire to be executed and delivered either in person or by its duly authorized agent.

 

	Dated:	 	 	Beneficial Owner:	 

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

    Annex B-5Corindus Vascular Robotics, Inc. 8-K

Exhibit 10.3

 

FIRST Amendment

to 

Loan
and security agreement (TERM LOAN)

 

This First Amendment
to Loan and Security Agreement (Term Loan) (this “Amendment”) is entered into this 14th day of March,
2019 among (a) SILICON VALLEY BANK, a California corporation (“SVB”), as collateral agent (in such capacity,
the “Collateral Agent”), (b) the lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time
to time including SVB in its capacity as a Lender and (c) SOLAR CAPITAL LTD., a Maryland corporation (“Solar”
and, together with SVB, each a “Lender” and collectively, the “Lenders”), and (d)(i) CORINDUS
VASCULAR ROBOTICS, INC., a Delaware corporation (“Parent Borrower”) whose address is 309 Waverly Oaks Road,
Suite 105, Waltham, Massachusetts 02452, and (ii) CORINDUS, INC., a Delaware corporation (“Subsidiary Borrower”)
whose address is 309 Waverly Oaks Road, Suite 105, Waltham, Massachusetts 02452 (Parent Borrower and Subsidiary Borrower are individually
and collectively, jointly and severally, “Borrower”).

 

Recitals

 

A.            Lender
and Borrower have entered into that certain Loan and Security Agreement (Term Loan) dated as of March 16, 2018 (as the same may
from time to time be amended, modified, supplemented or restated, the “Loan Agreement”).

 

B.            Lender
has extended credit to Borrower for the purposes permitted in the Loan Agreement.

 

C.            Borrower
has requested that Lender amend the Loan Agreement to (i) provide for a new term loan, and (ii) make certain other revisions to
the Loan Agreement as more fully set forth herein.

 

D.            Lender
has agreed to so amend certain provisions of the Loan Agreement, but only to the extent, in accordance with the terms, subject
to the conditions and in reliance upon the representations and warranties set forth below.

 

Agreement

 

Now,
Therefore, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy
of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

 

1.            Definitions.
Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement.

 

2.            Effectiveness.
The effectiveness of this Amendment is expressly conditioned upon the occurrence of the 2019 Equity Financing.

 

     

     

    

 

3.            Amendments
to Loan Agreement.

 

3.1           Section 2.2
(Term Loans). Section 2.2(a) of the Loan Agreement is amended in its entirety and replaced with the following:

 

“              (a)           Availability. Subject to the
terms and conditions of this Agreement and to the completion of the Initial Equity Financing, the Lenders agree, severally and
not jointly, to make one (1) advance to Borrower on the Effective Date in an aggregate original principal amount equal to Twelve
Million Dollars ($12,000,000.00) according to each Lender’s Term A Loan Commitment as set forth on Schedule 1.1 hereto
(the “Term A Loan”). After repayment, the Term A Loan (or any portion) may not be re-borrowed.”

 

3.2           Section 2.2
(Term Loans). Section 2.2(c) of the Loan Agreement is amended by deleting “each Term Loan” and inserting “the
Term A Loan” in lieu thereof.

 

3.3           Section 2.2
(Term Loans). Section 2.2(d) of the Loan Agreement is amended by deleting “Term Loans are” and inserting “Term
A Loan is” in lieu thereof.

 

3.4           Section 2.2
(Term Loans). Section 2.2(e) of the Loan Agreement is amended by deleting all references to “Term Loans” appearing
therein and inserting “Term A Loan” in lieu thereof.

 

3.5           Section 2.2.1
(2019 Term Loan). The Loan Agreement is amended by inserting the following new provision to appear as Section 2.2.1 (2019
Term Loan) thereof:

 

“              2.2.1
     2019 Term Loan.

 

(a)          Availability.
Subject to the terms and conditions of this Agreement and to the completion of the 2019 Equity Financing, the Lenders agree, severally
and not jointly, to make one (1) advance to Borrower on the First Amendment Effective Date in an aggregate original principal amount
equal to Two Million Seven Hundred Fifty Thousand Dollars ($2,750,000.00) according to each Lender’s 2019 Term Loan Commitment
as set forth on Schedule 1.1 hereto (the “2019 Term Loan”). After repayment, the 2019 Term Loan may not
be re-borrowed. The Term A Loan and 2019 Term Loan shall hereinafter be referred to singly as the “Term Loan”
and collectively as the “Term Loans.”

 

(b)          Interest
Period. Borrower shall make monthly payments of interest only, commencing on the first Payment Date following the First Amendment
Effective Date and continuing on the Payment Date of each successive month thereafter through and including March 1, 2020.

 

(c)          Repayment.
Commencing on April 1, 2020, and continuing on the Payment Date of each month thereafter, Borrower shall make to each Lender (i)
twenty-four (24) consecutive equal monthly installments of principal plus (ii) monthly payments of interest at the rate set forth
in Section 2.3(a). All unpaid principal and accrued and unpaid interest with respect to the 2019 Term Loan is due and payable in
full on the Term Loan Maturity Date.

 

     

     

    

 

(d)          Mandatory
Prepayments. If the 2019 Term Loan is accelerated following the occurrence of an Event of Default, Borrower shall immediately
pay to Lenders, payable to each Lender in accordance with its respective Pro Rata Share, an amount equal to the sum of: (i) all
outstanding principal of the Term Loans plus accrued and unpaid interest thereon through the prepayment date, (ii) the 2019 Final
Payment, (iii) the Prepayment Fee, if applicable, plus (iv) all other Obligations that are due and payable, including Lenders’
Expenses and interest at the Default Rate with respect to any past due amounts.

 

(e)          Permitted
Prepayment. Borrower shall have the option to prepay all, but not less than all, of the 2019 Term Loan advanced by the Lenders
under this Agreement, provided Borrower (i) provides written notice to Collateral Agent of its election to prepay the 2019 Term
Loan at least thirty (30) days prior to such prepayment, and (ii) pays to the Lenders on the date of such prepayment, payable to
each Lender in accordance with its respective Pro Rata Share, an amount equal to the sum of (A) all outstanding principal of the
2019 Term Loan plus accrued and unpaid interest thereon through the prepayment date, (B) the 2019 Final Payment, (C) the Prepayment
Fee, if applicable, plus (D) all other Obligations that are due and payable, including Lenders’ Expenses and interest at
the Default Rate with respect to any past due amounts.”

 

3.6           Section 2.5
(Fees). Section 2.5 is amended by (i) deleting “and” appearing at the end of subsection (c), (ii) re-lettering
subsection (d) as subsection (e), and (iii) inserting the following new subsection (d):

 

“              (d)           2019
Final Payment. The 2019 Final Payment, when due hereunder, to be shared between the Lenders pursuant to their respective Commitment
Percentage; and”

 

3.7           Section 6.2
(Financial Statements, Reports, Certificates). Section 6.2 is amended by (i) deleting the “and” appearing at the
end of subsection (g), (ii) re-lettering subsection (h) as subsection (i), and (iii) inserting the following new subsection (h):

 

“              (h)          prompt
written notice of any changes to the beneficial ownership information set out in Section 14 of the Perfection Certificate. Borrower
understands and acknowledges that Bank relies on such true, accurate and up-to-date beneficial ownership information to meet Bank’s
regulatory obligations to obtain, verify and record information about the beneficial owners of its legal entity customers; and”

 

     

     

    

 

3.8           Section 10
(Notices). Section 10 is amended in its entirety and replaced with the following:

 

“              10 Notices

 

All notices, consents, requests, approvals,
demands, or other communication by any party to this Agreement or any other Loan Document must be in writing and shall be deemed
to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after deposit
in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission,
when sent by electronic mail or facsimile transmission; (c) one (1) Business Day after deposit with a reputable overnight courier
with all charges prepaid; or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to
be notified and sent to the address, facsimile number, or email address indicated below. Any of Collateral Agent, any Lender or
Borrower may change its mailing or electronic mail address or facsimile number by giving the other party written notice thereof
in accordance with the terms of this Section 10.

 

		If to Borrower: 	Corindus Vascular Robotics, Inc.

                                                                                Corindus, Inc.

                                                                                309 Waverley Oaks Road,
Suite 105

                                                                                Waltham, Massachusetts
02452

                                                                                Attn: Chief Financial Officer (with a copy to
the Legal Department)

                                                                                Fax: (508) 232-6000

                                                                                Email: David.Long@corindus.com

  

		With a copy to:	Mintz, Levin, Cohn, Ferris, Glovsky and

                                                                                Popeo, P.C.

                                                                                One Financial Center

                                                                                Boston, Massachusetts

                                                                                Attn: Meryl J. Epstein, Esquire

                                                                                Fax: (617) 348-1635

                                                                                Email: MJEpstein@mintz.com

 

		If to Collateral Agent or SVB:	Silicon Valley Bank 

275 Grove Street, Suit
2-200

Newton, Massachusetts 02466

Attn: Mr. Sam Subilia

Fax: (617) 527-0177

Email: SSubilia@svb.com

 

		With a copy to:	Morrison & Foerster
LLP

20 Clarendon Street, Floor 20

Boston, Massachusetts 02116

Attn: David A. Ephraim, Esquire

Email: DEphraim@mofo.com

 

     

     

    

 

		If to Solar:	Solar Capital Ltd. 

500 Park Avenue, 3rd Floor 

New York, New York 10022 

Attn: Anthony Storino 

Fax: (212) 993-1698 

Email: Storino@solarcapltd.com

  

3.9           Section 13
(Definitions). The following terms and their respective definitions set forth in Section 13.1 are amended in their
entirety and replaced with the following:

 

“Obligations”
are Borrower’s obligations to pay when due any debts, principal, interest, fees, the Prepayment Fee, the Final Payment, the
2019 Final Payment, Lenders’ Expenses, and other amounts Borrower owes the Lenders now or later, whether under this Agreement,
the other Loan Documents (other than the Warrant or any equity instrument), or otherwise, including, without limitation, all obligations
relating to Bank Services and interest accruing after Insolvency Proceedings begin and debts, liabilities, or obligations of Borrower
assigned to the Lenders and/or Collateral Agent, and to perform Borrower’s duties under the Loan Documents.

 

“Term Loan” and
“Term Loans” are each defined in Section 2.2.1(a) hereof.

 

“Term A Loan”
is defined in Section 2.2(a) hereof.

 

“Warrant” is,
collectively, (a) that certain Warrant to Purchase Stock dated March 16, 2018 between Parent Borrower and SVB, (b) that certain
Warrant to Purchase Stock dated March 16, 2018 between Parent Borrower and Solar, (c) that certain Warrant to Purchase Stock dated
as of the First Amendment Effective Date between Parent Borrower and SVB, and (d) that certain Warrant to Purchase Stock dated
as of the First Amendment Effective Date between Parent Borrower and Solar, in each case as amended, modified, supplemented and/or
restated from time to time.

 

3.10        Section 13.1
(Definitions). The Loan Agreement is amended by inserting the following new terms and their respective definitions to appear
alphabetically in Section 13.1 thereof:

 

“2019 Equity Financing”
means receipt by Borrower, after February 26, 2019, but on or prior to the First Amendment Effective Date, of unrestricted (including,
without limitation, not being subject to any clawback, redemption, escrow or similar contractual restrictions) net cash proceeds
in an amount of at least Nineteen Million Dollars ($19,000,000.00) from the issuance of new equity securities of Parent Borrower.

 

     

     

    

 

“2019 Final Payment”
is a payment (in addition to and not a substitution for the regular monthly payments of principal plus accrued interest) in an
amount equal to One Hundred Sixty-Five Thousand Dollars ($165,000.00), due on the earliest to occur of (a) the Term Loan Maturity
Date, or (b) the acceleration of the 2019 Term Loan, or (c) the prepayment of the 2019 Term Loan pursuant to Section 2.2.1(d) or
Section 2.2.1(e), or (d) the repayment in full of all obligations under the 2019 Term Loan, or (e) the termination of this Agreement.

 

“2019 Term Loan”
is defined in Section 2.2.1(a) hereof.

 

“2019 Term Loan Commitment”
is, for any Lender, the obligation of such Lender to make a 2019 Term Loan, up to the principal amount shown on Schedule 1.1.

 

“First Amendment Effective
Date” is March 14, 2019.

 

3.11        Section 13.1
(Definitions). The following terms and their definitions set forth in Section 13.1 are deleted in their entirety:

 

“Draw Period B”
is the period of time commencing upon the occurrence of the Draw Period B Event and ending on the earlier to occur of (i) March
31, 2019 and (ii) the date of the occurrence of an Event of Default.

 

“Draw Period B Event”
means, on or prior to March 31, 2019, confirmation by Collateral Agent and Required Lenders that they have received satisfactory
evidence demonstrating that Borrower had gross profit (as determined under GAAP) of at least Four Million Five Hundred Thousand
Dollars ($4,500,000.00) for a six (6) consecutive month period ending after the Effective Date but on or before December 31, 2018.

 

“Draw Period C”
is the period of time commencing upon the occurrence of the Draw Period C Event and ending on the earlier to occur of (i) August
31, 2019 and (ii) the date of the occurrence of an Event of Default.

 

“Draw Period C Event”
means, on or prior to August 31, 2019, confirmation by Collateral Agent and Required Lenders that (a) the Term B Loan has been
made, (b) Collateral Agent and Required Lenders have received satisfactory evidence that Borrower received, after the Initial Equity
Financing but on or before June 30, 2019, unrestricted (including, without limitation, not being subject to any clawback, redemption,
escrow or similar contractual restriction) net cash proceeds in an amount of at least Thirty Million Dollars ($30,000,000.00) (exclusive
of any amounts raised from the Initial Equity Financing) from the issuance of new equity securities of Parent Borrower and (c)
Collateral Agent and Required Lenders have received satisfactory evidence demonstrating that Borrower had gross profit (as determined
under GAAP) of at least Eight Million Dollars ($8,000,000.00) for a six (6) consecutive month period ending after the Effective
Date but on or before August 31, 2019.

 

     

     

    

 

“Term B Loan”
is defined in Section 2.2(a)(ii) hereof.

 

“Term
B Loan Commitment” is, for any Lender, the obligation of such Lender to make a Term
B Loan, up to the principal amount shown on Schedule 1.1.

 

“Term C Loan”
is defined in Section 2.2(a)(iii) hereof.

 

“Term
C Loan Commitment” is, for any Lender, the obligation of such Lender to make a Term
C Loan, up to the principal amount shown on Schedule 1.1.

 

3.12        Schedule
1.1 (Lenders and Commitments). Schedule 1.1 (Lenders and Commitments) appearing as Schedule 1.1 to the Loan Agreement is deleted
in its entirety and replaced with the Schedule 1.1 (Lenders and Commitments) attached as Schedule 1 attached hereto.

 

3.13        Exhibit D
(Form of Secured Promissory Note). The Secured Promissory Note appearing as Exhibit D to the Loan Agreement
is deleted in its entirety and replaced with the Secured Promissory Note attached as Schedule 2 attached hereto. 

 

4.             Limitation
of Amendments.

 

4.1           The amendments
set forth in Section 3 above are effective for the purposes set forth herein and shall be limited precisely as written and shall
not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document,
or (b) otherwise prejudice any right or remedy which Bank may now have or may have in the future under or in connection with any
Loan Document.

 

4.2           This Amendment
shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties,
covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and shall
remain in full force and effect.

 

5.             Representations
and Warranties. To induce Bank to enter into this Amendment, Borrower hereby represents and warrants to Bank as follows:

 

5.1           Immediately
after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents are true, accurate
and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to
an earlier date, in which case they are true and correct as of such date), and (b) no Event of Default has occurred and is continuing;

 

     

     

    

 

 5.2          Borrower
has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as
amended by this Amendment;

 

 5.3          The
organizational documents of Borrower delivered to Bank on the Effective Date remain true, accurate and complete and have not been
amended, supplemented or restated and are and continue to be in full force and effect;

 

 5.4           The
execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement,
as amended by this Amendment, have been duly authorized;

 

5.5           The execution
and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended
by this Amendment, do not and will not contravene (a) any law or regulation binding on or affecting Borrower, (b) any contractual
restriction with a Person binding on Borrower, (c) any order, judgment or decree of any court or other governmental or public
body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower;

 

5.6           The execution
and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended
by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording
or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower,
except as already has been obtained or made; and

 

5.7            This Amendment
has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance
with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium
or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.

 

6.             Ratification
of Perfection Certificates. Parent Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures
contained in a certain Perfection Certificate of Parent Borrower dated as of March 16, 2018, as amended as set forth on Schedule
3 attached hereto (the “Parent Borrower Perfection Certificate”) and acknowledges, confirms and agrees
the disclosures and information Parent Borrower provided to Bank in said Perfection Certificate have not changed, as of the date
hereof. Subsidiary Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in
a certain Perfection Certificate of Subsidiary Borrower dated as of March 16, 2018, as amended as set forth on Schedule 4
attached hereto (the “Subsidiary Borrower Perfection Certificate”) and acknowledges, confirms and agrees the
disclosures and information Subsidiary Borrower provided to Bank in said Perfection Certificate have not changed, as of the date
hereof. Parent Borrower and Subsidiary Borrower each hereby agree that all references in the Loan Agreement to the “Perfection
Certificate” shall hereinafter be deemed to reference collectively the Parent Borrower Perfection Certificate and Subsidiary
Borrower Perfection Certificate, as defined herein.

 

     

     

    

 

7.            Post-Closing
Deliverables. Borrower shall deliver to Bank, on or before the date that is thirty (30) days after the First Amendment Effective
Date, evidence satisfactory to Bank that the insurance policies and endorsements for each Borrower required by Section 6.5 of
the Loan Agreement are in full force and effect, together with appropriate evidence showing lender loss payable and/or additional
insured clauses or endorsements in favor of Bank.

 

8.            Integration.
This Amendment and the Loan Documents represent the entire agreement about this subject matter and supersede prior negotiations
or agreements. All prior agreements, understandings, representations, warranties, and negotiations between the parties about the
subject matter of this Amendment and the Loan Documents merge into this Amendment and the Loan Documents.

 

9.            Reaffirmation.
Borrower hereby expressly (1) reaffirms, ratifies and confirms its Obligations under the Loan Agreement and the other Loan Documents,
(2) reaffirms, ratifies and confirms the grant of security under Section 4.1 of the Loan Agreement, (3) reaffirms that such grant
of security in the Collateral secures all Obligations under the Loan Agreement, including without limitation any Term Loans funded
on or after the First Amendment Effective Date, as of the date hereof, and with effect from (and including) the First Amendment
Effective Date, such grant of security in the Collateral: (x) remains in full force and effect notwithstanding the amendments
expressly referenced herein; and (y) secures all Obligations under the Loan Agreement, as amended by this Amendment, and the other
Loan Documents, (4) agrees that this Amendment shall be a “Loan Document” under the Loan Agreement and (5) agrees
that the Loan Agreement and each other Loan Document shall remain in full force and effect following any action contemplated in
connection herewith

 

10.          No
Novation. This Amendment is not a novation and the terms and conditions of this Amendment shall be in addition to and supplemental
to all terms and conditions set forth in the Loan Documents. Nothing in this Amendment is intended, or shall be construed, to
constitute an accord and satisfaction of Borrower’s Obligations under or in connection with the Loan Agreement and any other
Loan Document or to modify, affect or impair the perfection or continuity of Agent’s security interest in, (on behalf of
itself and the Lenders) security titles to or other liens on any Collateral for the Obligations.

 

11.          Prepayment
Fee, Final Payment and 2019 Final Payment. Borrower expressly agrees (to the fullest extent that each may lawfully do so)
that: (i) each of the Prepayment Fee, Final Payment and 2019 Final Payment is reasonable and is the product of an arm’s
length transaction between sophisticated business people, ably represented by counsel; (ii) each of the Prepayment Fee, Final
Payment and 2019 Final Payment shall be payable notwithstanding the then prevailing market rates at the time payment is made;
(iii) there has been a course of conduct between Collateral Agent, Lenders and Borrower giving specific consideration in this
transaction for such agreement to pay each of the Prepayment Fee, Final Payment and 2019 Final Payment and (iv) Borrower shall
be estopped hereafter from claiming differently than as agreed to in this paragraph. Borrower expressly acknowledges that its
agreement to pay each of the Prepayment Fee, Final Payment and 2019 Final Payment to Lenders as described in the Loan Agreement,
as amended, and was and continues to be a material inducement to Lenders to provide the Term Loan Commitments and make the Term
Loans.

 

     

     

    

 

12.           Counterparts.
This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to
constitute one and the same instrument.

 

13.           Effectiveness.
This Amendment shall be deemed effective upon (a) the due execution and delivery to Bank of this Amendment by each party hereto,
(b) Borrower’s payment to Bank of Bank’s legal fees and expenses incurred in connection with this Amendment, and (c)
the occurrence of the 2019 Equity Financing.

 

[Signature
page follows]

 

     

     

    

 

In
Witness Whereof, the parties hereto have caused
this Amendment to be duly executed and delivered as of the date first written above.

 

	COLLATERAL AGENT AND LENDER
	 	 	 	 	 	 
	SILICON VALLEY BANK	 	 	 	 
	 	 	 	 	 	 
	By:	/s/
    Sam Subilia	 	 	 	 
	Name:	Sam Subilia	 	 	 	 
	Title:	Vice President	 	 	 	 
	 	 	 	 	 	 
	BORROWER	 	 	 	 
	 	 	 	 	 	 
	CORINDUS, INC.	 	CORINDUS VASCULAR ROBOTICS, INC.	 
	 	 	 	 	 	 
	By:	/s/
    David W. Long	 	By:	/s/
    David W. Long	 
	Name:	David W. Long	 	Name:	David
    W. Long	 
	Title:	Chief
    Executive Officer	 	Title:	Chief
    Financial Officer and Senior Vice President	 
	 	 	 	 	 	 
	LENDER	 	 	 	 
	 	 	 	 	 	 
	SOLAR CAPITAL LTD.	 	 	 	 
	 	 	 	 	 	 
	By:	/s/
    Anthony J. Storino	 	 	 	 
	Name:	Anthony
    J. Storino	 	 	 	 
	Title:	Authorized Signatory	 	 	 	 

 

     

     

    

 

	 	 	 	 	 	 
	The undersigned hereby certifies,
    to the best of his or her knowledge, that the information set out in the Perfection Certificate is true, complete and correct.	 	 	 	 
	 	 	 	 	 	 
	CORINDUS, INC.	 	 	 
	 	 	 	 	 	 
	By:	 	 	 	 	 
	Name:	 	 	 	 	 
	Title:	 	 	 	 	 
	 	 	 	 	 	 
	CORINDUS VASCULAR ROBOTICS, INC.	 	 	 	 
	 	 	 	 	 	 
	By:	 	 	 	 	 
	Name:	 	 	 	 	 
	Title:	 	 	 	 	 

 

     

     

    

 

Schedule
1

 

Lenders
and Commitments

 

Term
A Loan

	Lender	Term
    A Loan Commitment	Commitment
    Percentage
	SOLAR
    CAPITAL LTD.	$6,782,608.68	56.521739%
	SILICON
    VALLEY BANK	$5,217,391.32	43.478261%
	TOTAL	$12,000,000.00	100.00%

 

2019
Term Loan

	Lender	2019
    Term Loan Commitment	Commitment
    Percentage
	SOLAR
    CAPITAL LTD.	$1,554,347.82	56.521739%
	SILICON
    VALLEY BANK	$1,195,652.18	43.478261%
	TOTAL	$2,750,000.00	100.00%

 

     

     

    

 

Schedule
2

 

Secured
Promissory Note

(Term
Loan A/2019 Term Loan)

 

	$ ________________	Dated: ________, 2019

 

FOR
VALUE RECEIVED, the undersigned, CORINDUS VASCULAR ROBOTICS, INC., a Delaware corporation with offices located at 309 Waverley
Oaks Road, Suite 105, Waltham, Massachusetts 02452, and CORINDUS, INC., a Delaware corporation with offices located at 309 Waverley
Oaks Road, Suite 105, Waltham, Massachusetts 02452 (jointly and severally, individually and collectively, “Borrower”)
HEREBY PROMISES TO PAY to the order of [SOLAR CAPITAL LTD.] [SILICON VALLEY BANK] (“Lender”) the principal amount
of [_______] MILLION DOLLARS ($_______) or such lesser amount as shall equal the outstanding principal balance of the [Term A
Loan/2019 Term Loan] made to Borrower by Lender, plus interest on the aggregate unpaid principal amount of such [Term A Loan/2019
Term Loan], at the rates and in accordance with the terms of the Loan and Security Agreement (Term Loan) dated March 16, 2018
by and among Borrower, Lender, as Collateral Agent, and the other Lenders from time to time party thereto (as amended, restated,
supplemented or otherwise modified from time to time, the “Loan Agreement”). If not sooner paid, the entire principal
amount and all accrued and unpaid interest hereunder shall be due and payable on the Term Loan Maturity Date as set forth in the
Loan Agreement. Any capitalized term not otherwise defined herein shall have the meaning attributed to such term in the Loan Agreement.

 

Borrower
agrees to pay any initial partial monthly interest payment from the date the [Term A Loan/2019 Term Loan] is made to Borrower
under this Secured Promissory Note (this “Note”) to the first Payment Date (“Interim Interest”) on the first
Payment Date.

 

Principal,
interest and all other amounts due with respect to the [Term A Loan/2019 Term Loan], are payable in lawful money of the United
States of America to Lender as set forth in the Loan Agreement and this Note. The principal amount of this Note and the interest
rate applicable thereto, and all payments made with respect thereto, shall be recorded by Lender and, prior to any transfer hereof,
endorsed on the grid attached hereto which is part of this Note.

 

The
Loan Agreement, among other things, (a) provides for the making of a secured [Term A Loan/2019 Term Loan] by Lender to Borrower,
and (b) contains provisions for acceleration of the maturity hereof upon the happening of certain stated events.

 

This
Note may not be prepaid except as set forth in [Section 2.2(d)/2.2.1(d) and Section 2.2(e)/2.2.1(e)] of the Loan Agreement.

 

This
Note and the obligation of Borrower to repay the unpaid principal amount of the [Term A Loan/2019 Term Loan], interest on the
[Term A Loan/2019 Term Loan] and all other amounts due Lender under the Loan Agreement is secured under the Loan Agreement.

 

Presentment
for payment, demand, notice of protest and all other demands and notices of any kind in connection with the execution, delivery,
performance and enforcement of this Note are hereby waived.

 

In
accordance with the terms of the Loan Agreement, Borrower shall pay all reasonable fees and expenses, including, without limitation,
reasonable attorneys’ fees and costs, incurred by Lender in the enforcement or attempt to enforce any of Borrower’s obligations
hereunder not performed when due.

 

This
Note shall be governed by, and construed and interpreted in accordance with, the internal laws of the State of New York.

 

     

     

    

 

The
ownership of an interest in this Note shall be registered on a record of ownership maintained by Lender or its agent. Notwithstanding
anything else in this Note to the contrary, the right to the principal of, and stated interest on, this Note may be transferred
only if the transfer is registered on such record of ownership and the transferee is identified as the owner of an interest in
the obligation. Borrower shall be entitled to treat the registered holder of this Note (as recorded on such record of ownership)
as the owner in fact thereof for all purposes and shall not be bound to recognize any equitable or other claim to or interest
in this Note on the part of any other person or entity.

 

     

     

    

 

IN
WITNESS WHEREOF, Borrower has caused this Note to be duly executed by one of its officers thereunto duly authorized on the date
hereof. 

	 	 	 	 	 	 
	BORROWER	 	 	 
	 	 	 	 	 	 
	CORINDUS,
                                         INC.	 	CORINDUS VASCULAR ROBOTICS, INC.	 
	 	 	 	 	 	 
	By:	 	 	By:	 	 
	Name:	 	 	Name:	 	 
	Title:	 	 	Title:	 	 
	 	 	 	 	 	 

 

     

     

    

 

Schedule
3

 

Corindus
Vascular Robotics, Inc.

 

Amendments
to Perfection Certificate

 

		1.	The
Perfection Certificate is amended by inserting the following text to appear as new Section 14 thereof, immediately following Section
13 thereof:

 

		“14.	BENEFICIAL
OWNERSHIP INFORMATION

 

		a.	Is
the Company any of the following:

 

		(i)	a
                                         public company or an issuer of securities that are registered with the Securities and
                                         Exchange Commission under Section 12 of the Securities Exchange Act of 1934 or that is
                                         required to file reports under Section 15(d) of that Act;

 

		(ii)	an
                                         investment company registered with the Securities and Exchange Commission under the Investment
                                         Company Act of 1940;

 

		(iii)	an
                                         investment adviser registered with the Securities and Exchange Commission under the Investment
                                         Advisers Act of 1940; or

 

		(iv)	a
                                         pooled investment vehicle operated or advised by a regulated financial institution (including
                                         an SEC-registered investment adviser)?

 

Yes    
 ☒       No       ☐

 

If
yes, no further information is required for Sections 14(b), 14(c) or 14(d) below. If no, continue to Section 14(b).

 

b.             Is
the Company a pooled investment vehicle that is not operated or advised by a regulated financial institution?

 

Yes    
 ☐       No       ☐

 

If
yes, skip to Section 14(d) below. If no, continue to Section 14(c).

 

c.             Does
any individual, directly or indirectly (for example, if applicable, through such individual’s equity
interests in the Company’s parent entity), through any contract, arrangement, understanding, relationship or otherwise,
own 25% or more of the equity interests of the Company:

 

Yes    
 ☐       No       ☐

 

     

     

    

 

If
yes, complete the following information. If no, continue to Section 14(d) below.

 

	 	Name	Date
    of birth	Residential
    address	For
                                         US Persons, Social Security Number:

         

        (non-US
        persons should provide SSN if available)

         
	For
    Non-US Persons: Type of ID, ID number, country of issuance, expiration date	Percentage
                                         of ownership

         

        (if
        indirect ownership, explain structure)

         

	1	 	 	 	 	 	 
	2	 	 	 	 	 	 
	3	 	 	 	 	 	 
	4	 	 	 	 	 	 

 

d.       Identify
one individual with significant responsibility for managing the Company, i.e., an executive officer or senior manager (e.g., Chief
Executive Officer, President, Vice President, Chief Financial Officer, Treasurer, Chief Operating Officer, Managing Member or
General Partner) or any other individual who regularly performs similar functions. If appropriate, an individual listed in Section
14(c) above may also be listed here.

 

	 	Name	Date
    of birth	Residential
    address	For
                                         US Persons, Social Security Number:

         

        (non-US
        persons should provide SSN if available)

         
	For
    Non-US Persons: Type of ID, ID number, country of issuance, expiration date
	1	  	 	 	 	 

 

     

     

    

 

Schedule
4

 

Corindus,
Inc.

 

Amendments
to Perfection Certificate

 

		1.	The
Perfection Certificate is amended by inserting the following text to appear as new Section 14 thereof, immediately following Section
13 thereof:

 

		“14.	 BENEFICIAL
OWNERSHIP INFORMATION

 

		a.	Is
the Company any of the following:

 

		(v)	a
                                         public company or an issuer of securities that are registered with the Securities and
                                         Exchange Commission under Section 12 of the Securities Exchange Act of 1934 or that is
                                         required to file reports under Section 15(d) of that Act;

 

		(vi)	an
                                         investment company registered with the Securities and Exchange Commission under the Investment
                                         Company Act of 1940;

 

		(vii)	an
                                         investment adviser registered with the Securities and Exchange Commission under the Investment
                                         Advisers Act of 1940; or

 

		(viii)	a
                                         pooled investment vehicle operated or advised by a regulated financial institution (including
                                         an SEC-registered investment adviser)?

 

Yes    
 ☐       No       ☒

 

If
yes, no further information is required for Sections 14(b), 14(c) or 14(d) below. If no, continue to Section 14(b).

 

b.            Is
the Company a pooled investment vehicle that is not operated or advised by a regulated financial institution?

 

Yes    
 ☐       No       ☒

 

If
yes, skip to Section 14(d) below. If no, continue to Section 14(c).

 

c.            Does
any individual, directly or indirectly (for example, if applicable, through such individual’s equity
interests in the Company’s parent entity), through any contract, arrangement, understanding, relationship or otherwise,
own 25% or more of the equity interests of the Company:

 

Yes    
 ☐       No       ☒

 

     

     

    

 

If
yes, complete the following information. If no, continue to Section 14(d) below.

 

	 	Name	Date
    of birth	Residential
    address	For
                                         US Persons, Social Security Number:

         

        (non-US
        persons should provide SSN if available)

         
	For
    Non-US Persons: Type of ID, ID number, country of issuance, expiration date	Percentage
                                         of ownership

         

        (if
        indirect ownership, explain structure)

         

	1	 	 	 	 	 	 
	2	 	 	 	 	 	 
	3	 	 	 	 	 	 
	4	 	 	 	 	 	 

 

d.       Identify
one individual with significant responsibility for managing the Company, i.e., an executive officer or senior manager (e.g., Chief
Executive Officer, President, Vice President, Chief Financial Officer, Treasurer, Chief Operating Officer, Managing Member or
General Partner) or any other individual who regularly performs similar functions. If appropriate, an individual listed in Section
14(c) above may also be listed here.

 

	 	Name	Date
    of birth	Residential
    address	For
                                         US Persons, Social Security Number:

         

        (non-US
        persons should provide SSN if available)

         
	For
    Non-US Persons: Type of ID, ID number, country of issuance, expiration date
	1	David
    W. Long

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00293-of-00352.parquet"}]]